Analysts from Royal Bank of Canada, Mizuho Securities, and Leerink partners issued rating and target price updates for Medtronic shares.
1 report, 1 independent
Updated Sep 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analysts from Royal Bank of Canada, Mizuho Securities, and Leerink partners issued rating and target price updates for Medtronic shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Royal Bank of Canada
financial institution in Canada
-
Mizuho Securities
Japanese investment banking company
Related events
- Mizuho Securities lowered its price target on Lam Research stock, while Berenberg Bank set a high target and Citigroup reiterated a buy rating.
- Mizuho Securities raised its price target on Dell Technologies.
- Financial institutions, including Royal Bank of Canada and Citigroup, raised price objectives and lifted target prices for Crown.
- Multiple analyst firms, including Needham, Mizuho, and Zacks, issued rating changes and coverage updates for Harmony Biosciences.